Clinical Assessment and Management of Occupational Asthma

Asthma in the Workplace and Related Conditions: Third Edition

Volumn , Issue , 2006, Pages 161-178

  Bernstein, David I ^a   Campo, Paloma ^a   Baur, Xaver ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136432214     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849374531-10     Document Type: Chapter

References (70)

1. Cartier A, Bernstein IL, Burge PS, et al. Guidelines for bronchoprovocation on the inves-tigation of occupational asthma. Report of the Subcommittee on Bronchoprovocation for Occupational Asthma. J Allergy Clin Immunol 1989; 84(5 Pt 2):823-829.
2. Smith AB, Castellan RM, Lewis D, Matte T. Guidelines for the epidemiologic assess-ment of occupational asthma. Report of the Subcommittee on the Epidemiologic Assess-ment of Occupational Asthma, Occupational Lung Disease Committee. J Allergy Clin Immunol 1989; 84(5 Pt 2):794-805.
3. Bernstein DI, Korbee L, Stauder T, et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engi-neered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993; 92(3): 387-396.
4. Bernstein JA. Material safety data sheets: are they reliable in identifying human hazards? J Allergy Clin Immunol 2002; 110(1):35-38.
5. Sallie B, McDonald C. Inhalation accidents reported to the SWORD surveillance project 1990-1993. Ann Occup Hyg 1996; 40(2):211-221.
6. Malo JL, Lemiere C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunc-tivitis in subjects with occupational asthma. Eur Respir J 1997; 10(7):1513-1515.
7. Perfetti L, Brame B, Ferrari M, Moscato G. Occupational asthma (OA) with sensitization to diphenylmethane diisocyanate (MDI) presenting at the onset like a reactive airways dysfunction syndrome (RADS). Am J Ind Med 2003; 44(3):325-328.
8. Chan-Yeung M, MacLean L, Paggiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol 1987; 79(5):792-796.
9. Moller DR, Brooks SM, McKay RT, Cassedy K, Kopp S, Bernstein IL. Chronic asthma due to toluene diisocyanate. Chest 1986; 90(4):494-499.
10. Venables KM, Upton JL, Hawkins ER, Tee RD, Longbottom JL, Newman Taylor AJ. Smoking, atopy, and laboratory animal allergy. Br J Ind Med 1988; 45(10):667-671.
11. Cartier A, Malo JL, Forest F, et al. Occupational asthma in snow crab-processing workers. J Allergy Clin Immunol 1984; 74(3 Pt 1):261-269.
12. Chan-Yeung M. Occupational asthma. Chest 1990; 98(suppl 5):148S-161S.
13. Sjostedt L, Willers S. Predisposing factors in laboratory animal allergy: a study of atopy and environmental factors. Am J Ind Med 1989; 16(2):199-208.
14. Liss, GM, Sussman GL, Deal K, et al. Latex allergy: epidemiological study of 1351 hospital workers. Occup Environ Med 1997; 54(5):335-342.
15. Taylor AJ, Venables KM, Durham SR, Graneek BJ, Topping MD. Acid anhydrides and asthma. Int Arch Allergy Appl Immunol 1987; 82(3-4):435-439.
16. Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med 2001; 163(4):899-904.
17. Hamilton RG, Adkinson NF Jr. Diagnosis of natural rubber latex allergy: multicenter latex skin testing efficacy study. Multicenter Latex Skin Testing Study Task Force. J Allergy Clin Immunol 1998; 102(3):482-490.
18. Koskela H, Taivainen A, Tukiainen H, Chan HK. Inhalation challenge with bovine dander allergens: who needs it? Chest 2003; 124(1):383-391.
19. Bernstein DI, Zeiss CR. Guidelines for preparation and characterization of chemical-protein conjugate antigens. Report of the Subcommittee on Preparation and Character-ization of Low Molecular Weight Antigens. J Allergy Clin Immunol 1989; 84(5 Pt 2): 820-822.
20. Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphe-nyldiisocyanate (MDI). J Allergy Clin Immunol 1988; 82(1):55-61.
21. Dijkman JH, Vooren PH, Kramps JA. Occupational asthma due to inhalation of chlor-amine-T. I. Clinical observations and inhalation-provocation studies. Int Arch Allergy Appl Immunol 1981; 64(4):422-427.
22. Bourne MS, Flindt ML, Walker JM. Asthma due to industrial use of chloramine. Br Med J 1979; 2(6181):10-12.
23. Merget R, Schultze-Werninghaus G, Bode F, Bergmann EM, Zachgo W, Meier-Sydow J. Quantitative skin prick and bronchial provocation tests with platinum salt. Br J Ind Med 1991; 48(12):830-837.
24. Cartier A, Grammer L, Malo JL, et al. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 1989; 84(4 Pt 1): 507-514.
25. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS. Indirect assessment of 4,4’-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med 1998; 33(5):471-477.
26. Park HS, Kim HY, Nahm DH, Son JW, Kim YY. Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J Allergy Clin Immunol 1999; 104(4 Pt 1):847-851.
27. Wisnewski AV, Stowe MH, Cartier A, et al. Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 2004; 113(6):1178-1184.
28. Wisnewski AV, Herrick CA, Liu Q, Chen L, Bottomly K, Redlich CA. Human gamma/ delta T-cell proliferation and IFN-gamma production induced by hexamethylene diiso-cyanate. J Allergy Clin Immunol 2003; 112(3):538-546.
29. Bernstein DI, Cartier A, Cote J, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002; 166(4): 445-450.
30. Burge PS. Single and serial measurements of lung function in the diagnosis of occupa-tional asthma. Eur J Respir Dis Suppl 1982; 123:47-59.
31. Leroyer C, Perfetti L, Trudeau C, L’Archeveque J, Chan-Yeung M, Malo JL. Compar-ison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupa-tional asthma. Am J Respir Crit Care Med 1998; 158(3):827-832.
32. Malo JL, Cote J, Cartier A, Boulet LP, L’Archeveque J, Chan-Yeung M. How many times per day should peak expiratory flow rates be assessed when investigating occupa-tional asthma? Thorax 1993; 48(12):1211-1217.
33. Malo JL, Trudeau C, Ghezzo H, L’Archeveque J, Cartier A. Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results? J Allergy Clin Immunol 1995; 96(5 Pt 1):601-607.
34. Quirce S, Contreras G, Dybuncio A, Chan-Yeung M. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am J Respir Crit Care Med 1995; 152(3):1100-1102.
35. Henneberger PK, Stanbury MJ, Trimbath LS, Kipen HM. The use of portable peak flowmeters in the surveillance of occupational asthma. Chest 1991; 100(6):1515-1521.
36. Tarlo SM, Broder I. Outcome of assessments for occupational asthma. Chest 1991; 100(2):329-335.
37. Perrin B, Lagier F, L’Archeveque J, et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J 1992; 5(1):40-48.
38. Moscato G, Godnic-Cvar J, Maestrelli P. Statement on self-monitoring of peak expira-tory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol 1995; 96(3):295-301.
39. Cartier A, Pineau L, Malo JL. Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthma. Clin Allergy 1984; 14(2):193-196.
40. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise chal-lenge testing-1999; This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Jul 1999. Am J Respir Crit Care Med 2000; 161(1):309-329.
41. Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 112(6):829-859.
42. Vandenplas O, Delwiche JP, Jamart J, Van de Weyer R. Increase in non-specific bron-chial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges. Thorax 1996; 51(5):472-478.
43. Lemiere C, Cartier A, Dolovich J, et al. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 1996; 154(2 Pt 1):329-333.
44. Sastre J, Fernandez-Nieto M, Novalbos A, De Las Heras M, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest 2003; 123(4):1276-1279.
45. Burge PS. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Thorax 1982; 37(5):348-353.
46. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164(8 Pt 1):1376-1381.
47. Kharitonov SA, O’Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151(6):1894-1899.
48. Gratziou C, Lignos M, Dassiou M, Roussos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999; 14(4):897-901.
49. Thomassen MJ, Raychaudhuri B, Dweik RA, et al. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol 1999; 104(6):1174-1182.
50. Lim S, Jatakanon A, Meah S, Oates T, Chung KF, Barnes PJ. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55(3):184-188.
51. Baur X, B.L. Latex allergen exposure increases exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Resp J. In press.
52. Obata H, Dittrick M, Chan H, Chan-Yeung M. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999; 13(3):489-495.
53. Youakim S. Work-related asthma. Am Fam Physician 2001; 64(11):1839-1848.
54. Girard F, Chaboillez S, Cartier A, et al. An Effective Strategy for Diagnosing Occupa-tional Asthma: Use of Induced Sputum. Am J Respir Crit Care Med 2004; 170(8): 845-850.
55. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83(2): 161-162.
56. Blanc PD, Boushey HA, Wong H, Wintermeyer SF, Bernstein MS. Cytokines in metal fume fever. Am Rev Respir Dis 1993; 147(1):134—138.
57. Malo JL, Cartier A. Occupational asthma due to fumes of galvanized metal. Chest 1987; 92(2):375-377.
58. Tarlo SM, Boulet LP, Cartier A, et al. Canadian Thoracic Society guidelines for occupational asthma. Can Respir J 1998; 5(4):289-300.
59. Guidelines for assessing and managing asthma risk at work, school, and recreation. Am J Respir Crit Care Med 2004; 169(7):873-881.
60. Malo JL, Ghezzo H, L’Archeveque J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 1991; 143(3):528-532.
61. Bardy JD, Malo JL, Seguin P, et al. Occupational asthma and IgE sensitization in a phar-maceutical company processing psyllium. Am Rev Respir Dis 1987; 135(5):1033-1038.
62. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002; J Allergy Clin Immunol 2002; 110(suppl 5):S141-S219.
63. Maestrelli P, De Marzo N, Saetta M, Boscaro M, Fabbri LM, Mapp CE. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate. Am Rev Respir Dis 1993; 148(2):407-412.
64. Ehrlich RI. Fatal asthma in a baker: a case report. Am J Ind Med 1994; 26(6):799-802.
65. Fabbri LM, Danieli D, Crescioli S, et al. Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 1988; 137(6):1494-1498.
66. Carino M, Aliani M, Licitra C, Sarno N, Ioli F. Death due to asthma at workplace in a diphenylmethane diisocyanate-sensitized subject. Respiration 1997; 64(1):111-113.
67. Wahn U, Siraganian RP. Efficacy and specificity of immunotherapy with laboratory animal allergen extracts. J Allergy Clin Immunol 1980; 65(6):413-421.
68. Sastre J, Fernandez-Nieto M, Rico P, et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2003; 111(5):985-994.
69. Leynadier F, Herman D, Vervloet D, Andre C. Specific immunotherapy with a standar-dized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 2000; 106(3):585-590.
70. Bernstein DI, Karnani R, Biagini RE, et al. Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol 2003; 90:209-213.